NOVA1
Reactivité: Humain
WB, ICC, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Peptide ELISA: 1/64000. Western Blot: 0.01 - 0.03 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
0,5 mg/mL
Buffer
Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
4 °C/-20 °C
Stockage commentaire
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
anticorps Nova-1, anticorps NOVA1, anticorps si:ch211-222c22.9, anticorps 9430099M15Rik, anticorps G630039L02, anticorps NOVA alternative splicing regulator 1, anticorps neuro-oncological ventral antigen 1 L homeolog, anticorps neuro-oncological ventral antigen 1, anticorps RNA-binding protein Nova-1, anticorps lipid A export ATP-binding/permease protein, anticorps NOVA1, anticorps Nova1, anticorps nova1.L, anticorps nova1, anticorps LOC790874, anticorps novA1
Sujet
Nova proteins are splicing factors that are expressed specifically in the central nervous system, where they regulate a large number of pre-mRNAs encoding synaptic proteins. Nova1 is a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer.Synonyms: Neuro-oncological ventral antigen 1, Onconeural ventral antigen 1, Paraneoplastic Ri antigen, RNA-binding protein Nova-1, Ventral neuron-specific protein 1